FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570290817> ?p ?o ?g. }

• W1570290817 abstract "Rheumatoid arthritis (RA) is a chronic systemic auto- immune disease characterized by joint synovitis. Recent evidence suggests that rheumatoid arthritis synovial fibroblasts (RASFs) promote joint destruction. In this study, we investigated the role of microRNA-26b (miR-26b) in cell proliferation and inflammatory cytokine secretion using patient-derived Rheumatoid arthritis fibroblast-like synoviocyte (RAFLS) to understand pathways influencing rheumatoid arthritis.RAFLS were cultured in vitro and transfected with miR-26b mimics (experimental group) and negative sequence (control group). The protein levels of Wnt4, Wnt5ɑ, GSK-3β, CyclinD1, Ser9-GSK-3β and β-catenin were detected by western blot analysis. Tumor Necrosis Factor-ɑ (TNF-ɑ), IL- 1β, and IL-6 levels were quantified by Enzyme-linked Immunosorbent Assay (ELISA). RAFLS proliferation and apoptosis were measured by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide (MTT) assay and flow cytometry, respectively.GSK-3β and CyclinD1 expression levels were lower in miR-26b mimic group compared to Mock group and negative control (NC) group. Conversely, GSK-3β and CyclinD1 expression levels were markedly higher in the miR-26b inhibitor group compared to Mock and NC group (P < 0.05). Transfection of miR-26b mimics significantly increased the, levels of Ser9-GSK-3β and β-catenin in comparison to Mock and NC groups, while transfection of miR-26b inhibitors showed the opposite effect. In miR-26b mimic group, TNF-α, IL- 1β and IL-6 levels were lower than the Mock and NC groups, while in miR-26b inhibitor group, these cytokine levels were higher than the Mock and NC groups (P < 0.05). Transfection of miR-26b mimics significantly reduced the cell proliferation of RAFLS, compared to the Mock and NC groups, and miR-26b inhibitors increased the proliferative capacity of RAFLS compared to Mock and NC groups (P < 0.05). The miR-26b mimic group exhibited higher RAFLS apoptosis rate compared to Mock and NC group and miR-26b inhibitor group showed significantly lower RAFLS apoptosis rate compared to Mock and NC groups (P < 0.05).MiR-26b regulates β-catenin and CyclinD1 levels by inhibiting GSK-3β expression, which in-turn alters the Wnt/GSK-3β/β-catenin pathway to lower RAFLS proliferation and elevate cell apoptosis and the secretion of TNF-α,IL-1β and IL-6 cytokines. Therefore, our results show that miR-26B plays a central role in inhibiting the inflammation associated with rheumatoid arthritis.The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9063056861547150." @default.
• W1570290817 created "2016-06-24" @default.
• W1570290817 creator A5013446684 @default.
• W1570290817 creator A5016432495 @default.
• W1570290817 creator A5041762312 @default.
• W1570290817 creator A5053992438 @default.
• W1570290817 creator A5059717228 @default.
• W1570290817 creator A5066866404 @default.
• W1570290817 creator A5078940906 @default.
• W1570290817 creator A5085031591 @default.
• W1570290817 date "2015-06-19" @default.
• W1570290817 modified "2023-10-10" @default.
• W1570290817 title "MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway" @default.
• W1570290817 cites W1967167881 @default.
• W1570290817 cites W1968142189 @default.
• W1570290817 cites W1970592677 @default.
• W1570290817 cites W1971722955 @default.
• W1570290817 cites W1972906526 @default.
• W1570290817 cites W1974976948 @default.
• W1570290817 cites W1977718569 @default.
• W1570290817 cites W1978644929 @default.
• W1570290817 cites W1979206745 @default.
• W1570290817 cites W1984514451 @default.
• W1570290817 cites W1986843662 @default.
• W1570290817 cites W1988963557 @default.
• W1570290817 cites W1994992849 @default.
• W1570290817 cites W2002428403 @default.
• W1570290817 cites W2010430872 @default.
• W1570290817 cites W2012632125 @default.
• W1570290817 cites W2012989450 @default.
• W1570290817 cites W2013375004 @default.
• W1570290817 cites W2014578524 @default.
• W1570290817 cites W2023729916 @default.
• W1570290817 cites W2026962303 @default.
• W1570290817 cites W2028067469 @default.
• W1570290817 cites W2030176363 @default.
• W1570290817 cites W2042397391 @default.
• W1570290817 cites W2047943933 @default.
• W1570290817 cites W2050850788 @default.
• W1570290817 cites W2056841944 @default.
• W1570290817 cites W2057093679 @default.
• W1570290817 cites W2065543285 @default.
• W1570290817 cites W2083364674 @default.
• W1570290817 cites W2088152440 @default.
• W1570290817 cites W2098267886 @default.
• W1570290817 cites W2102507295 @default.
• W1570290817 cites W2105718763 @default.
• W1570290817 cites W2106501933 @default.
• W1570290817 cites W2107398008 @default.
• W1570290817 cites W2111992170 @default.
• W1570290817 cites W2113546559 @default.
• W1570290817 cites W2117673199 @default.
• W1570290817 cites W2117839723 @default.
• W1570290817 cites W2134185120 @default.
• W1570290817 cites W2135495626 @default.
• W1570290817 cites W2137659055 @default.
• W1570290817 cites W2148276874 @default.
• W1570290817 cites W2152348310 @default.
• W1570290817 cites W2153961241 @default.
• W1570290817 cites W2163169629 @default.
• W1570290817 cites W2163229196 @default.
• W1570290817 cites W2167939282 @default.
• W1570290817 cites W2171977041 @default.
• W1570290817 cites W2278114299 @default.
• W1570290817 cites W2317077142 @default.
• W1570290817 cites W2419082664 @default.
• W1570290817 cites W763316186 @default.
• W1570290817 doi "https://doi.org/10.1186/s13000-015-0309-x" @default.
• W1570290817 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4472173" @default.
• W1570290817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26088648" @default.
• W1570290817 hasPublicationYear "2015" @default.
• W1570290817 type Work @default.
• W1570290817 sameAs 1570290817 @default.
• W1570290817 citedByCount "68" @default.
• W1570290817 countsByYear W15702908172016 @default.
• W1570290817 countsByYear W15702908172017 @default.
• W1570290817 countsByYear W15702908172018 @default.
• W1570290817 countsByYear W15702908172019 @default.
• W1570290817 countsByYear W15702908172020 @default.
• W1570290817 countsByYear W15702908172021 @default.
• W1570290817 countsByYear W15702908172022 @default.
• W1570290817 countsByYear W15702908172023 @default.
• W1570290817 crossrefType "journal-article" @default.
• W1570290817 hasAuthorship W1570290817A5013446684 @default.
• W1570290817 hasAuthorship W1570290817A5016432495 @default.
• W1570290817 hasAuthorship W1570290817A5041762312 @default.
• W1570290817 hasAuthorship W1570290817A5053992438 @default.
• W1570290817 hasAuthorship W1570290817A5059717228 @default.
• W1570290817 hasAuthorship W1570290817A5066866404 @default.
• W1570290817 hasAuthorship W1570290817A5078940906 @default.
• W1570290817 hasAuthorship W1570290817A5085031591 @default.
• W1570290817 hasBestOaLocation W15702908171 @default.
• W1570290817 hasConcept C104317684 @default.
• W1570290817 hasConcept C126322002 @default.
• W1570290817 hasConcept C137620995 @default.
• W1570290817 hasConcept C145059251 @default.
• W1570290817 hasConcept C153911025 @default.
• W1570290817 hasConcept C17991360 @default.
• W1570290817 hasConcept C185592680 @default.
• W1570290817 hasConcept C203014093 @default.

• next